(Total Views: 359)
Posted On: 09/17/2020 12:26:55 PM
Post# of 108

$PVCT News Article - Provectus Biopharmaceuticals Announces Presentation of Preliminary Data from Combination Therapy Trial of PV-10 and KEYTRUDA for Checkpoint-Refractory Advanced Cutaneous Melanoma at ESMO Virtual Congress 2020 https://marketwirenews.com/news-releases/prov...75250.html


My Twitter: WhyteStocks